Rarer syndromes characterized by hypogonadotropic hypogonadism

Frontiers of Hormone Research

Volumn 39, Issue , 2010, Pages 154-167

  Aminzadeh, Majid ^a   Kim, Hyung Goo ^b   Layman, Lawrence C ^b   Cheetham, Timothy D ^c,d  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CITALOPRAM; CLOMIFENE CITRATE; ESTROGEN; GONADORELIN; LEPTIN; NUCLEAR RECEPTOR DAX 1; PROPROTEIN CONVERTASE 1; RECOMBINANT LEPTIN; SEX HORMONE; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADRENAL GLAND MALFORMATION; ANDROGEN THERAPY; AZOOSPERMIA; BARDET BIEDL SYNDROME; CLINICAL FEATURE; COMPETITIVE INHIBITION; CONGENITAL ADRENAL HYPOPLASIA; CRYPTORCHISM; DRUG DOSE INCREASE; ENDOCRINE DISEASE; ENZYME DEFICIENCY; GENE DELETION; GENETIC ANALYSIS; GONADOTROPIN DEFICIENCY; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KALLMANN SYNDROME; LEPTIN DEFICIENCY; LIFE EXPECTANCY; LOW DRUG DOSE; MICROPENIS; PATHOPHYSIOLOGY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROPROTEIN CONVERTASE 1 DEFICIENCY; PROTEIN DEFICIENCY; QUALITY OF LIFE; REVIEW; SERTOLI CELL; SPERMATOGENESIS; SYNDROME; SYNDROME CHARGE; TREATMENT DURATION;

ADRENAL HYPERPLASIA, CONGENITAL; ANIMALS; BARDET-BIEDL SYNDROME; CHARGE SYNDROME; DAX-1 ORPHAN NUCLEAR RECEPTOR; FEMALE; GENETIC DISEASES, X-LINKED; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; LEPTIN; MALE; MICE; PRADER-WILLI SYNDROME; PROPROTEIN CONVERTASE 1;

EID: 84925955922     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000312701     Document Type: Review

References (28)

1. Eiholzer U, Lee PDK: Medical considerations in Prader-Willi syndrome; in Butler MG, Lee PDK, Whitman BY (eds): Management of Prader-Willi Syndrome, ed 3. New York, Springer, 2006, pp 97-152.
2. Eiholzer U, l'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Grüters A, Simoni M: Hypothalamic and gonadal components of hypogo-nadism in boys with Prader-Labhart-Willi syndrome. J Clin Endocrinol Metab 2006;91:892-898.
3. Muscatelli F, Abrous DN, Massacrier A, Boccaccio I, Le Moal M, Cau P, Cremer H: Disruption of the mouse Necdin gene results in hypothalamic and behavioural alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 2000;9: 3101-3110.
4. Miller NL, Wevrick R, Mellon PL: Necdin, a Prader-Willi candidate gene, regulated gonadotropin-releasing hormone neurons during development. Hum Mol Genet 2009;18:248-260.
5. Eiholzer U, Grieser J, Schlumpf M, L'Allemand D: Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome. Horm Res 2007;68:178-184.
6. Sanlaville D, Verloes A: CHARGE syndrome: an update. Eur J Hum Genet 2007;15:389-399.
7. Blake KD, Davenport SLH, Hall BD, Hefner MA, Pagon RA, Williams MS, Lin AE, Graham JM: CHARGE association: an update and review for the primary pediatrician. Clin Pediatr 1998;37:59-173.
8. Verloes A: Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet 2005;133A: 306-308.
9. Asakura Y, Toyota Y, Muroya K, Kurosawa K, Fujita K, Aida N, Kawame H, Kosaki K, Adachi M: Endocrine and radiological studies in patients with molecularly confirmed CHARGE syndrome. J Clin Endocrinol Metab 2008;93:920-924.
10. Wheeler PG, Quigley CA, Sadeghi-Nejad A, Weaver DD: Hypogonadism and CHARGE association. Am J Med Genet 2000;94:228-231.
11. Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC, Schoenmakers EF, Brunner HG, Veltman JA, van Kessel AG: Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004;36:955-957.
12. Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ, Walker SL, Shi Y, Gusella JF, Layman LC: Mutations in CHD7, encoding a chro-matin-remodeling protein, cause idiopathic hypog-onadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2008;83:511-519.
13. Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-van der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF Jr, Hoefsloot LH: CHD7 mutations in patients initially diagnosed with Kallmann syndrome-the clinical overlap with CHARGE syndrome. Clin Genet 2009;75:65-71.
14. Zanaria, E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker A P, McCabe ER Meitinger T, Monaco A P, Sassone-Corsi P, Camerino G: An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635-641.
15. Muscatelli F, Strom TM, Walker A P, Zanaria E, Récan D, Meindl A, Bardoni B, Guioli S, Zehetner G, Rabl W, Schwarz H P, Kaplan JC, Camerino G, Meitinger T, Monaco AP: Mutations in the DAX1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-676.
16. Shaikh MG, Boyes L, Kingston H, Collins R, Besley GT, Padmakumar B, Ismayl O, Hughes IA, Hall CM, Hellerud C, Achermann JC, Clayton PE: Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenital. J Med Genet 2008;45:e1-e5.
17. Takahashi T, Shoji Y, Shoji Y, Haraguchi N, Takahashi I, Takada G: Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita. J Pediatr 1997;130: 485-488.
18. Tabarin A, Achermann JC, Recan D, Bex V, Bertagna X, Christin-Maitre S, Ito M, Jameson JL, Bouchard P: A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonado-tropic hypogonadism. J Clin Invest 2000;105:321-328.
19. Domenice S, Latronico AC, Brito VN, Arnhold IJP, Kok F, Mendonca BB: Adrenocorticotropin-depen-dent precocious puberty of testicular origin in a boy with x-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene. J Clin Endocrinol Metab 2001;86:4068-4071.
20. Montague CT, Farooqi IS, Whitehead J P, Soos MA, Rau H, Wareham NJ, Sewter C P, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
21. Farooqi IS, Wangensteen T, Collins S, et al: Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007;356: 237-247.
22. Farooqi IS, Matarese G, Lord GM: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110: 1093-1103.
23. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzoros CS: Recombinant human leptin in women with hypothalamic amen-orrhea. N Engl J Med 2004;351:987-997.
24. Jackson RS, Creemers J W, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the human prohor-mone convertase 1 gene. Nat Genet 1997;16:303-306.
25. Jackson RS, Creemers JW, Farooqi IS, et al: Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 2003;112:1550-1560.
26. Farooqi IS, Volders K, Stanhope RG, Heuschkel R, White A, Lank E, Keogh J, O'Rahilly S, Creemers JW: Hyperphagia and early-onset obesity due to a novel homoxygous mutation in prohormone con-vertase 1/3. J Clin Endocrinol Metab 2007;92:3369-3373.
27. Zaghloul NA, Katsanis N: Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest 2009;119:428-437.
28. Harville HM, Held S, Diaz-Font A, Davis EE, Diplas BH, Lewis RA, Borochowitz ZU, Zhou W, Chaki M, Macdonald J, Kayserili H, Beales PL, Katsanis N, Otto E, Hildebrandt F: Identification of 11 novel mutations in 8 BBS genes by high-resolution homozygosity mapping. J Med Genet 2009, Epub ahead of print.